PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy to Prevent Neutropenia
Clinical trial NCT02805205 · COMPLETED
Trial details
- NCT number
- NCT02805205
- Sponsor
- CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2016-02-01
- Enrollment
- 484
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.